In FOI-3727 Pfizer reports to 15 April 2022 196 different "Pregnancy, puerperium and perinatal conditions" including cases: Postpartum haemorrhage 26 Intrapartum haemorrhage 4 Peripartum haemorrhage 4 Postpartum disorder 2 Postpartum state 2 Postpartum venous thrombosis 2 Third stage postpartum haemorrhage 1
In FOI-3727 Pfizer reports to 15 April 2022
196 different "Pregnancy, puerperium and perinatal conditions" including cases:
Postpartum haemorrhage 26
Intrapartum haemorrhage 4
Peripartum haemorrhage 4
Postpartum disorder 2
Postpartum state 2
Postpartum venous thrombosis 2
Third stage postpartum haemorrhage 1
undefined subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
In FOI-3727 Pfizer reports to 15 April 2022
196 different "Pregnancy, puerperium and perinatal conditions" including cases:
Postpartum haemorrhage 26
Intrapartum haemorrhage 4
Peripartum haemorrhage 4
Postpartum disorder 2
Postpartum state 2
Postpartum venous thrombosis 2
Third stage postpartum haemorrhage 1